Navigation Links
First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
Date:6/16/2008

NEW ORLEANS, La.Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting. The prototype scanner already has proven successful in better characterizing partial epilepsy and nasopharyngeal cancer. Eventually, the technology could be used to provide early-stage diagnoses of other cancers, neurological disorders and cardiovascular disease; assess patients' responses to therapies; and determine the efficacy of new drugs.

"This is an exciting development in the field of nuclear medicine," said Yuichi Morimoto, senior researcher for the Central Research Laboratory of Hitachi Ltd., Tokyo, Japan, and lead researcher of the study, Performance of a Prototype Brain PET Scanner Based on Semiconductor Detectors. "Our research indicates semiconductor scanners show great potential because of their high energy resolution and flexibility in both sizing and fine arrangement of detectors. These characteristics should lead to improved PET images and, in turn, major advances in the practice of nuclear medicine."

Molecular imaging procedures such as PET scans are noninvasive and painless medical tests that help physicians diagnose medical conditions or conduct research. PET scans involve the use of radioactive materials called radiopharmaceuticals or radiotracers, which eventually collect in the area being examined and give off energy in the form of gamma rays. This energy is detected by a PET scanner and/or probe. These devices work together with a computer to measure the amount of radiotracer absorbed and to produce special pictures offering details on the function of organs and other internal body parts down to the cellular and molecular levels.

Semiconductor-based detectors could improve PET imaging capabilities because the smaller, thinner semiconductors are easier to adjust and arrange than conventional scanners. The new technology allows for even higher spatial resolution and less "noise," or irrelevant images. The prototype semiconductor brain scanner also employs a depth of interaction (DOI) detection system, which reduces errors at the periphery of the field of view.

Researchers evaluated the physical performance of the prototype scanner and studied the technology's clinical significance in patients suffering from partial epilepsy and nasopharyngeal cancera relatively rare form of cancer that develops at the top of the throat, behind the nose. The results indicate that the PET scanner is feasible for clinical use and has good potential for providing the higher spatial resolution and quantitative imaging required in nuclear medicine. This device, which has been installed in Hokkaido University Hospital, is a result of successful collaboration with staff from the Department of Nuclear Medicine at Hokkaido University in Sapporo, Japan.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation ... Physics and Astronomy, has been selected for membership in ARCS Alumni Hall of ... Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of the ...
Breaking Biology Technology:
(Date:8/15/2017)... Va. , Aug. 15 2017   ivWatch LLC , ... of intravenous (IV) therapy, today announced receipt of its ISO 13485 ... developed by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the ... "This is ...
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/16/2017)...  Veratad Technologies, LLC ( www.veratad.com ), an innovative ... verification solutions, announced today they will participate as a ... thru May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions ... evolving digital world, defining identity is critical to nearly ...
Breaking Biology News(10 mins):